Martin Meglasson Net Worth & Insider Trades

Martin Meglasson - Chief Scientific Officer, Bellerophon Therapeutics, Inc

As of May 22, 2015

What is Martin Meglasson's Net Worth?

The current estimated net worth of Bellerophon Therapeutics, Inc's Chief Scientific Officer, Martin Meglasson, is estimated to be about $225.32K . Martin Meglasson owns about 19,098 units of Bellerophon Therapeutics, Inc common stock. In the last 3 months at Bellerophon Therapeutics, Inc, Martin Meglasson has sold an estimated value of $0 worth.

What is Martin Meglasson's Past Insider Trading?

Martin Meglasson's largest purchase order was 12,000 units , worth over $144K on February 23, 2015. In total, Martin Meglasson has made about 4 transactions over 3 months of their time at Bellerophon Therapeutics, Inc. Martin Meglasson usually trades in February, with the busiest year in 2015. The most recent transaction was a purchase order of 712 units , worth over $5.98K on May 22, 2015.

Martin Meglasson

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Martin Meglasson's' Mailing Address?

  • Mailing address is 53 Frontage Road, Suite 301 Hampton NJ 08827 NJ

What are Bellerophon Therapeutics, Inc's Past Insider Trades?

Bellerophon Therapeutics, Inc's most recent insider trade came on March 22, 2021 by New Mountain Investments Ii Llc, New Mountain Capital Llc and Steven Klinsky who sold 400,000 units worth $2.19M . In the last 6 years, insiders at Bellerophon Therapeutics, Inc have sold an estimated value of $4.02M and bought an estimated value of $74.83M worth of shares. Insider trading is most common in September, with the busiest year in 2018. The most active traders at the company are Jonathan M Peacock,  Theodore T Wang,  and Peter Fernandes, CHIEF EXECUTIVE OFFICER .

Bellerophon Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...